96 related articles for article (PubMed ID: 10606735)
41. Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase.
Nguyen M; Alfonso A; Johnson CD; Rand JB
Genetics; 1995 Jun; 140(2):527-35. PubMed ID: 7498734
[TBL] [Abstract][Full Text] [Related]
42. DRP-1-mediated apoptosis induces muscle degeneration in dystrophin mutants.
Scholtes C; Bellemin S; Martin E; Carre-Pierrat M; Mollereau B; Gieseler K; Walter L
Sci Rep; 2018 May; 8(1):7354. PubMed ID: 29743663
[TBL] [Abstract][Full Text] [Related]
43. Altered Function of the DnaJ Family Cochaperone DNJ-17 Modulates Locomotor Circuit Activity in a Caenorhabditis elegans Seizure Model.
Takayanagi-Kiya S; Jin Y
G3 (Bethesda); 2016 Jul; 6(7):2165-71. PubMed ID: 27185401
[TBL] [Abstract][Full Text] [Related]
44. ace-3 plays an important role in phoxim resistance in Caenorhabditis elegans.
Han Y; Song S; Guo Y; Zhang J; Ma E
Ecotoxicology; 2016 May; 25(4):835-44. PubMed ID: 26947509
[TBL] [Abstract][Full Text] [Related]
45. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
Wang B; Li J; Fu FH; Xiao X
J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234
[TBL] [Abstract][Full Text] [Related]
46. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
47. Additional genes which result in an elevation of acetylcholine levels by mutations in Caenorhabditis elegans.
Hosono R; Kamiya Y
Neurosci Lett; 1991 Jul; 128(2):243-4. PubMed ID: 1945043
[TBL] [Abstract][Full Text] [Related]
48. Caenorhabditis elegans sqt-3 mutants have mutations in the col-1 collagen gene.
van der Keyl H; Kim H; Espey R; Oke CV; Edwards MK
Dev Dyn; 1994 Sep; 201(1):86-94. PubMed ID: 7803850
[TBL] [Abstract][Full Text] [Related]
49. Mutation of the feh-1 gene, the Caenorhabditis elegans orthologue of mammalian Fe65, decreases the expression of two acetylcholinesterase genes.
Bimonte M; Gianni D; Allegra D; Russo T; Zambrano N
Eur J Neurosci; 2004 Sep; 20(6):1483-8. PubMed ID: 15355315
[TBL] [Abstract][Full Text] [Related]
50. Hyperactivation of L-type voltage-gated Ca2+ channels in Caenorhabditis elegans striated muscle can result from point mutations in the IS6 or the IIIS4 segment of the α1 subunit.
Lainé V; Ségor JR; Zhan H; Bessereau JL; Jospin M
J Exp Biol; 2014 Nov; 217(Pt 21):3805-14. PubMed ID: 25214488
[TBL] [Abstract][Full Text] [Related]
51. Dystrobrevin requires a dystrophin-binding domain to function in Caenorhabditis elegans.
Grisoni K; Gieseler K; Ségalat L
Eur J Biochem; 2002 Mar; 269(6):1607-12. PubMed ID: 11895430
[TBL] [Abstract][Full Text] [Related]
52. Two invertebrate acetylcholinesterases show activation followed by inhibition with substrate concentration.
Marcel V; Palacios LG; Pertuy C; Masson P; Fournier D
Biochem J; 1998 Jan; 329 ( Pt 2)(Pt 2):329-34. PubMed ID: 9425116
[TBL] [Abstract][Full Text] [Related]
53. Human alpha- and beta-NRXN1 isoforms rescue behavioral impairments of Caenorhabditis elegans neurexin-deficient mutants.
Calahorro F; Ruiz-Rubio M
Genes Brain Behav; 2013 Jun; 12(4):453-64. PubMed ID: 23638761
[TBL] [Abstract][Full Text] [Related]
54. Locomotion Behavior Is Affected by the Gα
Gottschling DC; Döring F; Lüersen K
Genetics; 2017 May; 206(1):283-297. PubMed ID: 28341653
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects.
Diegoli M; Grasso M; Favalli V; Serio A; Gambarin FI; Klersy C; Pasotti M; Agozzino E; Scelsi L; Ferlini A; Febo O; Piccolo G; Tavazzi L; Narula J; Arbustini E
J Am Coll Cardiol; 2011 Aug; 58(9):925-34. PubMed ID: 21851881
[TBL] [Abstract][Full Text] [Related]
56. The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter.
Alfonso A; Grundahl K; Duerr JS; Han HP; Rand JB
Science; 1993 Jul; 261(5121):617-9. PubMed ID: 8342028
[TBL] [Abstract][Full Text] [Related]
57. C. elegans dystroglycan DGN-1 functions in epithelia and neurons, but not muscle, and independently of dystrophin.
Johnson RP; Kang SH; Kramer JM
Development; 2006 May; 133(10):1911-21. PubMed ID: 16611689
[TBL] [Abstract][Full Text] [Related]
58. The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans.
Guest M; Bull K; Walker RJ; Amliwala K; O'Connor V; Harder A; Holden-Dye L; Hopper NA
Int J Parasitol; 2007 Dec; 37(14):1577-88. PubMed ID: 17583712
[TBL] [Abstract][Full Text] [Related]
59. Mutants carrying two sma mutations are super small in the nematode C. elegans.
Watanabe N; Ishihara T; Ohshima Y
Genes Cells; 2007 May; 12(5):603-9. PubMed ID: 17535251
[TBL] [Abstract][Full Text] [Related]
60. Aberrant Activation of p38 MAP Kinase-Dependent Innate Immune Responses Is Toxic to Caenorhabditis elegans.
Cheesman HK; Feinbaum RL; Thekkiniath J; Dowen RH; Conery AL; Pukkila-Worley R
G3 (Bethesda); 2016 Jan; 6(3):541-9. PubMed ID: 26818074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
